Arvinas (ARVN) Capital Expenditures (QoQ) (2018 - 2026)
Arvinas (ARVN) Capital Expenditures (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.46 Bn | 470.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.19 Bn | 115.94 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.44 Bn | 60.69 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - |
| 8 | Argenx Se | 57.08 Bn | 51.90 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.11 Bn | 38.11 Bn | - |
| 10 | Arvinas | 531.20 Mn | -83.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 192.86% |
| Dec 31, 2025 | -1,500.00% |
| Sep 30, 2025 | -91.67% |
| Jun 30, 2025 | 200.00% |
| Mar 31, 2025 | 33.33% |
| Dec 31, 2024 | -57.14% |
| Sep 30, 2024 | -12.50% |
| Dec 31, 2023 | -90.91% |
| Sep 30, 2023 | 83.33% |
| Jun 30, 2023 | -45.45% |
| Mar 31, 2023 | 650.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 87.50% |
| Jun 30, 2022 | -176.19% |
| Mar 31, 2022 | 425.00% |
| Dec 31, 2021 | 128.57% |
| Sep 30, 2021 | -380.00% |
| Jun 30, 2021 | -50.00% |
| Mar 31, 2021 | -82.21% |
| Dec 31, 2020 | 333.46% |